Västra Hamnen Corp. Finance

Magle Chemoswed: Targeting profitability

  • Net sales in Q3 fell short of our estimates
  • High margin business areas continue to thrive
  • We maintain our valuation interval SEK 46.60 – 62.80 SEK per share

Magle Chemoswed’s Q3 2022 sales came in below our estimates as manufacturing revenue had a weak quarter. The effects of the sales dip in the CDMO category were mitigated by a strong quarter for royalty sales which resulted in a healthy bottom line. Magle Chemoswed continues to shift towards high-margin business areas such as DSM sales and royalties combined with a solid cost control. During the quarter, the company has initiated an investment program to increase production capacity for proprietary products.

The full report is available here.

Datum 2022-11-14, kl 08:30
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!